Notification No.:
Date: 8th October 2024
Relevant Act / Rule: Goods and Service Tax Act, 2017
The Ministry of Finance has issued Notification No. 05/2024-Central Tax (Rate), effective from October 10, 2024, which revises GST rates for various goods:
1. Cancer drugs such as Trastuzumab Deruxtecan, Osimertinib, and Durvalumab: Reduced to 5% (from 12%).
2. Extruded or expanded savory snacks (HS 1905 90 30): Reduced to 12% (from 18%).
3. Car and motorcycle seats (HS 9401): Increased to 28% (from 18%).
Similar notifications have been issued for UTGST and Integrated Tax rates.
Notification link:
https://taxinformation.cbic.gov.in/view-pdf/1010170/ENG/Notifications
Disclaimer: The information contained in this Article is intended solely for personal non-commercial use of the user who accepts full responsibility of its use. The information in the article is general in nature and should not be considered to be legal, tax, accounting, consulting or any other professional advice. We make no representation or warranty of any kind, express or implied regarding the accuracy, adequacy, reliability or completeness of any information on our page/article.